Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Other Operating Expenses (2015 - 2026)

Acadia Pharmaceuticals (ACAD) posted Other Operating Expenses of $28.3 million for Q2 2026, up 14.22% on a QoQ basis from $24.8 million in Q1 2026, and up 36.57% year-over-year from $20.7 million in Q2 2025.

Analysis

Acadia Pharmaceuticals (ACAD) Other Operating Expenses (2015 - 2026) Analysis & Trends

Acadia Pharmaceuticals has reported Other Operating Expenses for 12 years, with the latest figure at $28.3 million in Q2 2026.

  • On a quarterly basis, Other Operating Expenses rose 36.57% year-over-year to $28.3 million in Q2 2026; TTM through Jun 2026 was $101.0 million, a 256.0% increase from a year earlier, with the FY2024 full-year figure at $146.5 million, changed N/A from the prior year.
  • Other Operating Expenses was $28.3 million for Q2 2026 at Acadia Pharmaceuticals, up from $24.8 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $28.3 million in Q2 2026, with the low at -$124.7 million in Q4 2024.
  • Average Other Operating Expenses over 5 years is $7.2 million, with a median of $18.1 million recorded in 2023.
  • The largest YoY upside for Other Operating Expenses was 1276.78% in 2024 against a maximum downside of 797.07% in 2024.
  • Over 5 years, Other Operating Expenses stood at $2.4 million in 2022, then surged by 641.44% to $17.9 million in 2023, then slumped by 797.07% to -$124.7 million in 2024, then jumped by 121.03% to $26.2 million in 2025, then gained by 7.97% to $28.3 million in 2026.
  • The last three Other Operating Expenses figures came in at $28.3 million (Q2 2026), $24.8 million (Q1 2026), and $26.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.32 Mn
Mar 31, 2026 24.79 Mn
Dec 31, 2025 26.23 Mn
Sep 30, 2025 21.65 Mn
Jun 30, 2025 20.73 Mn
Mar 31, 2025 20.39 Mn
Dec 31, 2024 -124.71 Mn
Sep 30, 2024 18.86 Mn
Jun 30, 2024 18.23 Mn
Mar 31, 2024 22.95 Mn
Dec 31, 2023 17.89 Mn
Sep 30, 2023 14.62 Mn
Jun 30, 2023 7.46 Mn
Mar 31, 2023 1.67 Mn
Dec 31, 2022 2.41 Mn
Sep 30, 2022 2.14 Mn
Jun 30, 2022 2.67 Mn
Mar 31, 2022 2.95 Mn
Dec 31, 2021 2.56 Mn
Sep 30, 2021 6.68 Mn
API Access

Acadia Pharmaceuticals Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ACAD&period=max&api_key=YOUR_API_KEY